Literature DB >> 32004189

Combining Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Apparent Diffusion Coefficient Maps for a Radiomics Nomogram to Predict Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients.

Xiangguang Chen1, Xiaofeng Chen, Jiada Yang, Yulin Li, Weixiong Fan, Zhiqi Yang.   

Abstract

OBJECTIVE: The objective of this study was to develop a nomogrom for prediction of pathological complete response (PCR) to neoadjuvant chemotherapy in breast cancer patients.
METHODS: Ninety-one patients were analyzed. A total of 396 radiomics features were extracted from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and apparent diffusion coefficient (ADC) maps. The least absolute shrinkage and selection operator was selected for data dimension reduction to build a radiomics signature. Finally, the nomogram was built to predict PCR.
RESULTS: The radiomics signature of the model that combined DCE-MRI and ADC maps showed a higher performance (area under the receiver operating characteristic curve [AUC], 0.848) than the models with DCE-MRI (AUC, 0.750) or ADC maps (AUC, 0.785) alone in the training set. The proposed model, which included combined radiomics signature, estrogen receptor, and progesterone receptor, yielded a maximum AUC of 0.837 in the testing set.
CONCLUSIONS: The combined radiomics features from DCE-MRI and ADC data may serve as potential predictor markers for predicting PCR. The nomogram could be used as a quantitative tool to predict PCR.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32004189     DOI: 10.1097/RCT.0000000000000978

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  6 in total

1.  Prediction of pathological complete response using radiomics on MRI in patients with breast cancer undergoing neoadjuvant pharmacotherapy.

Authors:  Yuka Kuramoto; Natsumi Wada; Yoshikazu Uchiyama
Journal:  Int J Comput Assist Radiol Surg       Date:  2022-01-12       Impact factor: 2.924

2.  Quantitative Multiparametric MRI as an Imaging Biomarker for the Prediction of Breast Cancer Receptor Status and Molecular Subtypes.

Authors:  Zhiqi Yang; Xiaofeng Chen; Tianhui Zhang; Fengyan Cheng; Yuting Liao; Xiangguan Chen; Zhuozhi Dai; Weixiong Fan
Journal:  Front Oncol       Date:  2021-09-16       Impact factor: 6.244

3.  A Novel Combined Nomogram Model for Predicting the Pathological Complete Response to Neoadjuvant Chemotherapy in Invasive Breast Carcinoma of No Specific Type: Real-World Study.

Authors:  Xuelin Zhu; Jing Shen; Huanlei Zhang; Xiulin Wang; Huihui Zhang; Jing Yu; Qing Zhang; Dongdong Song; Liping Guo; Dianlong Zhang; Ruiping Zhu; Jianlin Wu
Journal:  Front Oncol       Date:  2022-06-06       Impact factor: 5.738

4.  Readout-Segmented Echo-Planar Diffusion-Weighted MR Imaging Improves the Differentiation of Breast Cancer Receptor Statuses Compared With Conventional Diffusion-Weighted Imaging.

Authors:  Minghao Zhong; Zhiqi Yang; Xiaofeng Chen; Ruibin Huang; Mengzhu Wang; Weixiong Fan; Zhuozhi Dai; Xiangguang Chen
Journal:  J Magn Reson Imaging       Date:  2022-01-17       Impact factor: 5.119

5.  Radiomics Features Based on MRI-ADC Maps of Patients with Breast Cancer: Relationship with Lesion Size, Features Stability, and Model Accuracy.

Authors:  Begumhan Baysal; Hakan Baysal; Mehmet Bilgin Eser; Mahmut Bilal Dogan; Orhan Alimoglu
Journal:  Medeni Med J       Date:  2022-09-21

6.  Application of MRI Radiomics-Based Machine Learning Model to Improve Contralateral BI-RADS 4 Lesion Assessment.

Authors:  Wen Hao; Jing Gong; Shengping Wang; Hui Zhu; Bin Zhao; Weijun Peng
Journal:  Front Oncol       Date:  2020-10-29       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.